Highest-materiality recent filing
Cycurion acquires Secuvant for ~$2.875M; expects $3M revenue, $1.5M EBITDA in FY 2026
Total consideration $2.875M: $875K cash (staged) + 888,888 Series I preferred shares (~$2.0M).
Merger consideration includes $1.0M cash, $1.5M in Cycurion common stock, and $2.0M, $2.5M, $3.0M annual installment payments.
Cycurion Q1 2026 net loss cut 51.5%; gross margin up 900 bps; acquires Halo/HavenX for $7M revenue
Q1 2026 revenue $3.3M; gross margin 21.1% (up 900 bps QoQ); net loss $2.6M, improved 51.5% from Q4 2025.
Cycurion acquires Halo Privacy and HavenX; deal brings $5.5M ARR, close in 45 days
Halo Privacy (~$7M revenue, $5.5M ARR, ~55% gross margin) and its HavenX investigations arm acquired by Cycurion.
Cycurion wins $6M purchase order from major U.S. municipality; backlog reaches $112M
Multi-year MSA/IDIQ contract with three-year base term and two one-year options.
Cycurion reports $112M backlog, $1.35M new health contract revenue; trading at 0.5x revenue
$112M contracted backlog provides multi-year revenue visibility; public health contracts to add $1.35M in 2026 revenue ($1.165M ARR).
Cycurion updates on $112M backlog, cost cuts, lawsuit; targets margin expansion
Contracted backlog of ~$112M provides multi-year revenue visibility; public health contracts add $1.35M revenue ($1.165M new ARR).
Cycurion accelerates MOU closing for Kustom video solutions; reports $2.2M cost cuts
Both parties target closing by early June 2026, accelerating from prior timeline.
Cycurion sends litigation hold letters to 16 market makers in manipulation probe
Litigation hold letters issued to 16 market makers requiring preservation of all CYCU trading records from Feb 16 to Mar 23, 2026.
Cycurion names defamation defendant, wins $1M/year Fortune 500 contract
Identified Michael S. Emo as anonymous poster; filed amended complaint in EDVA (Case 1:26-cv-00489) seeking compensatory and punitive damages.
Revenue $15.1M (-15% YoY); net loss $(23.7)M vs $1.2M income in FY2024.
Cycurion wins $1.35M in new public health contracts; $1.165M ARR
Two new multi-year awards from a large healthcare government agency and NACCHO.
Cycurion reports false $150M acquisition press release; shareholder vote approves warrant exercise
Shareholders approved issuance of up to 3,314,920 shares upon warrant exercise (2,359,348 for, 164,438 against).
Cycurion signs MOU to acquire Kustom's video-solutions division for $6-8.4M
Deal valued at $6.0-8.4 million; paid in $1.0-1.4M cash + Cycurion preferred stock convertible at 20% premium to 30-day VWAP.
Cycurion reports $80M backlog, Q3 revenue $3.83M, Q1 2026 run-rate $4.17M forecasted
Q3 revenue $3.83M (-13.9% YoY); gross profit $0.27M (7.1% margin).
Cycurion raises $6M in private placement with single institutional investor
Gross proceeds of $6M from sale of 1,657,460 shares (or pre-funded warrants) and 3,314,920 warrants at $3.62/unit.
Cycurion awarded Florida statewide management consulting contract; eligible for ~$90M annual spend
Awarded position on Florida Management Consulting Services State Term Contract under RFP No. 25-80101500-RFP-V2.
Q3 revenue $3.83M (down 14% YoY), net loss $3.24M, backlog >$80M, regains Nasdaq compliance
Q3 revenue $3.83M (down 13.9% YoY), net loss $3.24M ($1.59 loss per share).
Cycurion named approved vendor under Florida State Term Contract for IT Staff Augmentation
Multi-year contract allows Florida state agencies, counties, and municipalities to engage Cycurion directly without competitive bidding.
Cycurion completes 1:30 reverse stock split; Nasdaq delisting appeal hearing set for Nov 20, 2025
1:30 reverse stock split effective Oct 27, 2025; shares reduced from ~86.5M to ~2.88M.
Cycurion implements 1-for-30 reverse stock split effective Oct 27 to maintain Nasdaq compliance
Outstanding shares reduced from ~86.5M to ~2.9M, par value unchanged at $0.0001 per share.
Cycurion receives Nasdaq delisting notice; plans 30:1 reverse split and appeal
Nasdaq staff determined to delist CYCU common stock due to bid price below $1 for 30 consecutive days; appeal filed Oct 20 stays suspension pending hearing (30-45 days).
Cycurion approves 3x share increase, reverse split; amends iQSTEL stock swap
Authorized shares increased from 100M to 300M; reverse stock split ratio range 3:1 to 75:1 (aggregate cap 250:1).
Cycurion announces $4.6M in new contracts, total backlog reaches $73.6M
New contracts total $4.6M, adding to $69M for a total backlog of $73.6M.
Cycurion and IQSTEL execute $1M stock swap with planned dividend distribution to shareholders
Each company will issue $1 million of common stock to the other; share count based on lower of prior day close or 5-day average Nasdaq price.
Cycurion exchanges $3.2M debt for Series G Preferred shares; plans reverse split and ELOC draw
Exchanged $3,132,657 total debt from seven investors for 3,133 shares of Series G Convertible Preferred Stock.
Cycurion reports $69M contracted backlog and regains Nasdaq compliance
$69M contracted backlog from multi-year awards (1-5 yr life); incremental to existing revenue; small revenue recognized to date.
Q2 revenue down 22% to $3.9M; net loss $5.3M; $69M in new contracts; adj. loss $0.04/shr
Q2 net revenues $3.9M (-22.3% YoY); gross profit $0.2M (-77%); net loss $5.3M vs income $0.3M in Q2 2024.
Cycurion authorizes Series G Convertible Preferred Stock with 12% dividend and conversion rights
Authorized 10,000 shares of Series G Convertible Preferred Stock, par value $0.0001 per share.
Authorized 100 shares of Series E Convertible Preferred Stock (par $0.0001, convertible 1:10,000 common) and 10,000 shares of Series F (par $0.0001, convertible 1:1,000, 12% annual dividend).
Cycurion and IQSTEL sign MOU for $1M stock exchange; half of shares as dividend
Each company issues $1M worth of common stock to the other; shares valued at lower of closing price or 5-day average.
Cycurion unveils NACCHO Cyber Shield partnership; projects $20M in revenue over 3 years
Partnered with NACCHO to provide Cyber Shield cybersecurity solution to public health organizations nationwide.
Cycurion secures over $8M in new contracts including $6M transit agency deal
Total new contracts exceed $8 million with government and commercial clients.
the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.
Cycurion, Inc. (the “Company”) announced that Alvin McCoy III, the Company’s Chief Financial Officer, will step down from his position effective May 31, 2026.
On April 13, 2026, Irving Minnaker resigned from the Board of Directors (the "Board") of Cycurion, Inc. (the "Company") and from any and all offices that he holds with the Company, effective as from February 14, 2026.
Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.
Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.
Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.
Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.
Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.
Max materiality 0.90 · Median 0.65 · Most common event other_material